Fmoc-DL-Nle-OH

Fmoc-DL-Nle-OH is a fluorenylmethoxycarbonyl (Fmoc) protected amino acid derivative of norleucine (Nle), supplied as a racemic DL mixture that contains a stereogenic center at the α-carbon. The molecule features an Fmoc-protected primary amine for controlled peptide coupling, a free carboxylic acid for C-terminal activation, and a straight-chain aliphatic side chain that can participate in hydrophobic interactions within peptide sequences. The presence of the Fmoc carbamate enables orthogonal protection logic in solid-phase peptide synthesis, while the unprotected acid can be converted into activated esters or amide-forming intermediates under standard peptide chemistry conditions. As a chiral amino acid intermediate in racemic form, Fmoc-DL-Nle-OH supports downstream derivatization and scaffold construction where side-chain hydrophobicity and backbone incorporation are the primary design variables.

1. Peptide Synthesis

Fmoc-DL-Nle-OH is applied in peptide building block preparation for both solution-phase and solid-phase peptide synthesis workflows. The Fmoc-protected amine supports reliable N-terminal deprotection/deprotection-triggered coupling cycles, while the free carboxylic acid is compatible with peptide coupling chemistry to form amide bonds at the C-terminus. The DL stereochemistry means the resulting peptide sequences incorporate norleucine in a racemic manner at the relevant position, which can be used when stereochemical uniformity is not required or when screening multiple stereochemical outcomes is acceptable. Hydrophobic, unbranched side-chain geometry from the Nle residue can be leveraged to tune folding propensity, membrane affinity, or protease recognition patterns in peptide analog libraries. Fmoc-DL-Nle-OH thus functions as a practical amino acid ester-free protected amino acid derivative for constructing norleucine-containing peptides and peptide fragments.

2. Peptidomimetics

Fmoc-DL-Nle-OH is used in peptidomimetic and molecular scaffold design where an aliphatic amino acid residue is incorporated to modulate lipophilicity and shape complementarity. The straight-chain side chain provides a predictable hydrophobic element that can be carried through iterative coupling steps during synthetic assembly of peptidomimetic backbones. The Fmoc group enables stepwise N-protection management, supporting assembly of constrained analogs or backbone-modified sequences that retain an amide-rich architecture. The carboxylic acid functionality supports conversion to amide linkages and can be carried into further transformations that generate substituted derivatives for SAR studies. Fmoc-DL-Nle-OH therefore serves as a stereochemically mixed chiral amino acid intermediate for constructing norleucine-like motifs in synthetic organic chemistry.

3. Side-Chain Functionalization

Fmoc-DL-Nle-OH is suitable for side-chain functionalization strategies that begin from a protected amino acid platform and proceed through downstream derivatization of the norleucine residue. The Fmoc-protected amine allows selective manipulation of the carboxyl group and subsequent coupling, while the unbranched aliphatic side chain can be adapted through chemical transformations that introduce additional functional handles for conjugation or receptor-binding studies. The racemic α-carbon does not impede side-chain derivatization steps, enabling synthesis of derivative sets that vary in functional group identity while maintaining the same carbon skeleton. The molecule can be used to prepare intermediates for further amino acid modification, including analogs bearing reactive moieties for subsequent attachment to biomolecules or solid supports. Fmoc-DL-Nle-OH thereby supports amino acid derivatization routes that connect protected amino acid synthesis with functional group installation.

4. Chemical Biology

Fmoc-DL-Nle-OH is applied in chemical biology research for generating peptide-based probes and biochemical research intermediates that incorporate hydrophobic norleucine residues. The Fmoc-protected amine supports controlled peptide construction, enabling placement of the Nle residue at defined positions within probe sequences used for studying binding interfaces, substrate preferences, or protein-peptide interactions. The free carboxylic acid and resulting amide linkages provide stable connection points for assembling longer constructs that can be further modified with tags or affinity handles. DL stereochemistry can be leveraged for exploratory studies where stereochemical resolution is not the primary variable, allowing rapid access to norleucine-containing probe panels. Fmoc-DL-Nle-OH thus functions as a protected amino acid derivative for peptide science workflows that connect synthetic methodology with molecular recognition experiments.

5. Pharmaceutical Manufacturing

Fmoc-DL-Nle-OH is relevant to pharmaceutical manufacturing and specialty chemical production contexts that require protected amino acid intermediates for controlled peptide intermediate preparation. The Fmoc protection strategy is compatible with established peptide synthesis supply chains, where orthogonal N-protection and deprotection logic supports predictable coupling operations during manufacturing of peptide intermediates and peptide-like intermediates for downstream processing. The presence of a carboxylic acid enables conversion into activated species during intermediate formation steps, supporting consistent formation of amide-linked fragments used in process chemistry. The hydrophobic Nle side chain can be used in manufacturing routes for peptide building blocks that require aliphatic residue incorporation to tune solubility, aggregation behavior, or solid-state handling characteristics of peptide intermediates. Fmoc-DL-Nle-OH therefore serves as a process-compatible amino acid derivative for industrial peptide construction and fine chemical synthesis where protected amino acid handling is central.

6. Analytical Research

Fmoc-DL-Nle-OH is utilized in analytical research for preparing reference standards and internal calibration materials associated with norleucine-containing peptides and amino acid derivatives. The Fmoc group enables straightforward incorporation into defined peptide sequences that can be used to validate chromatographic retention behavior, fragmentation patterns, and method selectivity in peptide analytics. The free carboxylic acid and resulting amide connectivity support generation of defined standards that reflect the same backbone and side-chain hydrophobicity as target analytes. DL stereochemistry can be advantageous for analytical method development when racemic incorporation is expected or when the method aims to quantify total norleucine-containing species without requiring enantiomer-specific separation. Fmoc-DL-Nle-OH thus supports analytical standard development and biochemical research intermediate generation for LC-MS and related peptide characterization workflows.

1. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

2. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

3. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

4. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

5. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef